Unified cloud-native solution streamlines R&D workflows from in silico design to scale-up manufacturing.
Seoul, South Korea — June 29, 2025 —
SyntecBio, a leader in AI‐driven biotechnology innovation, today announced the launch of its Integrated Biotech Platform, a comprehensive cloud-based system that unifies computational design, automated lab execution, and bioprocess scale-up into a single, seamless workflow. By bridging data silos and automating critical steps across the biologics development pipeline, the platform reduces project timelines by up to 40% and accelerates go-to-market for novel therapies and industrial bioproducts.
Key Features & Benefits
End-to-End Workflow Integration
Consolidates gene design, strain optimization, fermentation, and analytics into one portal—eliminating manual handoffs and data fragmentation.
AI-Enhanced Design Studio
Leverages deep-learning models to propose optimized genetic constructs and pathway modifications, cutting design cycles by 50%.
Robotic Lab Automation
Compatible with major liquid-handling robots and plate readers to execute experiments at scale with minimal human intervention.
Scalable Bioprocess Module
Simulates and controls bench to pilot-scale fermentations, enabling rapid techno-economic assessments and scale-up planning.
Collaborative Data Hub
Secure, role-based access and audit trails ensure real-time collaboration between R&D teams, manufacturing partners, and regulatory stakeholders.
Executive Quote
“Our Integrated Biotech Platform represents a paradigm shift for our customers,” said Dr. Jane Lee, CEO of SyntecBio. “By unifying computational design, automated experimentation, and scalable bioprocessing, we empower scientists and engineers to move faster, reduce costs, and deliver breakthrough solutions that improve human health and sustainability.”
Early Deployments & Use Cases
Therapeutic Developers
Streamlining antibody discovery and optimization to accelerate clinical candidate selection.
Industrial Biotechnology
Enabling rapid prototyping of microbial cell factories for specialty chemicals and biofuels.
Academic Consortia
Facilitating multi-institutional research collaborations with shared data spaces and protocol libraries.
To explore how SyntecBio’s Integrated Biotech Platform can accelerate your next project, request a personalized demo at www.syntecbiofuel.com
About SyntecBio
SyntecBio is a Seoul-based innovator at the intersection of artificial intelligence and synthetic biology. Founded in 2018, the company’s mission is to deliver end-to-end biotechnology solutions that make drug development and biomanufacturing more efficient, sustainable, and accessible. Learn more at www.syntecbio.com.
Media Contact
Lee Min-joon
Director, Global Communications, SyntecBio